We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+21.44%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$6.97B
AUM Growth
+$492M
Cap. Flow
-$515M
Cap. Flow %
-7.39%
Top 10 Hldgs %
91.74%
Holding
29
New
Increased
2
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
PHVS icon
Pharvaris
PHVS
+$35.4M
2
LOGC
ContextLogic
LOGC
+$5

Sector Composition

Rank Sector Weight
1 Technology 59.07%
2 Healthcare 19.55%
3 Financials 11.32%
4 Industrials 6.2%
5 Consumer Staples 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
$2.07B 29.66%
90,271,540
DLO icon
2
dLocal
DLO
$4.28B
$1.13B 16.22%
63,906,695
XP icon
3
XP
XP
$8.36B
$772M 11.08%
29,617,733
ALHC icon
4
Alignment Healthcare
ALHC
$3.81B
$525M 7.53%
60,993,323
ALKT icon
5
Alkami Technology
ALKT
$1.96B
$454M 6.52%
18,729,806
HRT
6
DELISTED
HireRight Holdings Corporation
HRT
$432M 6.2%
32,109,898
SQSP
7
DELISTED
Squarespace, Inc.
SQSP
$350M 5.03%
10,611,073
-6,000,000
-36% -$176M
KRTX
8
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$312M 4.48%
986,710
EWCZ
9
DELISTED
European Wax Center
EWCZ
$178M 2.56%
13,110,492
PHVS icon
10
Pharvaris
PHVS
$2.26B
$173M 2.48%
6,156,252
+1,750,000
+40% +$35.4M
CNTA
11
DELISTED
Centessa Pharmaceuticals
CNTA
$77.1M 1.11%
9,681,818
HCM icon
12
HUTCHMED
HCM
$1.96B
$72.4M 1.04%
4,000,000
IMCR icon
13
Immunocore
IMCR
$1.68B
$64.9M 0.93%
950,000
MBLY icon
14
Mobileye
MBLY
$2.03B
$57.1M 0.82%
1,318,782
-3,443,123
-72% -$136M
BLND icon
15
Blend Labs
BLND
$436M
$48.8M 0.7%
19,132,440
RPRX icon
16
Royalty Pharma
RPRX
$26.6B
$42.1M 0.6%
1,500,000
YOU icon
17
Clear Secure
YOU
$5.68B
$41.9M 0.6%
2,028,797
-1,948,645
-49% -$37.9M
AKRO
18
DELISTED
Akero Therapeutics
AKRO
$41.7M 0.6%
1,785,714
THRD
19
DELISTED
Third Harmonic Bio
THRD
$32.5M 0.47%
2,958,762
OPEN icon
20
Opendoor
OPEN
$3.65B
$28.3M 0.41%
6,532,236
RSKD icon
21
Riskified
RSKD
$727M
$24.9M 0.36%
5,324,998
SLRN
22
DELISTED
ACELYRIN
SLRN
$21.6M 0.31%
2,889,668
FUTU icon
23
Futu Holdings
FUTU
$14.3B
$16.9M 0.24%
309,255
-798,072
-72% -$45.3M
LOGC
24
DELISTED
ContextLogic
LOGC
$3.63M 0.05%
609,616
+1
+0% +$5
GROV icon
25
Grove Collaborative
GROV
$45.4M
$1.66M 0.02%
936,020

Similar funds

General Atlantic's Q4 2023 Portfolio in Review

As of Q4 2023, General Atlantic held 29 positions worth $6.97B, up 7.6% from $6.48B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

General Atlantic withdrew a net $515M in Q4 2023, closing 3 positions and reducing 4 holdings. Its most notable exit was Duolingo, an estimated $96.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 59% of assets, down from 60% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic added an estimated $35.4M to Pharvaris.

  • General Atlantic added most to Pharvaris in Q4 2023, an estimated $35.4M increase.
  • General Atlantic's biggest Q4 2023 reduction was Squarespace, Inc., cutting an estimated $176M.
  • General Atlantic fully exited Duolingo in Q4 2023, selling an estimated $96.3M.
  • General Atlantic's ten largest holdings make up 92% of its $6.97B portfolio in Q4 2023.
  • General Atlantic opened 0 new positions and closed 3 in Q4 2023.
  • General Atlantic's portfolio value rose 7.6% quarter-over-quarter to $6.97B.

Based on General Atlantic's 13F filing for Q4 2023, filed 13 Feb 2024.